Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
Ankle Plantar Flexion Endurance Test

Jan 10, 2013/Test & Measure

Assesses plantar flexion endurance in weight bearing.

Falls Risk Assessment Tool (FRAT)

Oct 1, 2014/Test & Measure

This is a popular, moderately predictive, reliable and brief method of screening fall risk in subacute and residential aged care.

CMS Releases Final 2026 Medicare Advantage Rule

Apr 30, 2025/News

The rule offers limited insight into the new administration's plans for MA policy.

Upper Extremity Functional Scale (UEFS)

Aug 22, 2017/Test & Measure

This is an eight-item scale that examines a person’s level of function when performing activities that are related to Upper Extremity Disorders.

Multiple Sclerosis (MS) Functional Composite (MSFC)

Jan 5, 2024/Test & Measure

Measures limitations and unidimensionality of prior existing functional status outcomes such as the Expanded Disability Status Scale (EDSS).

New Study Reimagines the Relationship Between Daily Steps and Health Outcomes

Sep 3, 2025/Article

For decades, 10,000 steps a day has been regarded as a near-universal benchmark for fitness and general health goals — often promoted by wearable fitness trackers and public health campaigns. However, an August 2025 study, "Daily steps and health outcomes in adults: a systematic review and dose-response

Get to Know APTA Home Health: An Interview With Academy President Philip Goldsmith

Dec 10, 2024/Podcast

A brief introduction from the president of the academy.

What Is PTPAC? Five Things You Need to Know

Feb 3, 2023/News

Our political action committee is working on issues that matter now and into the profession's future.

New Member Benefit a One-Stop-Shop for Prior Authorization, UM Advocacy Tools

Mar 15, 2022/News

APTA and the Private Practice Section have collaborated to create SPARC — the State Payer Advocacy Resource Center.

Rivermead Mobility Index for Multiple Sclerosis (MS)

Sep 12, 2013/Test & Measure

Target population: People with multiple sclerosis (MS).